These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Paroxetine in the first trimester and the prevalence of congenital malformations. Cole JA, Ephross SA, Cosmatos IS, Walker AM. Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1075-85. PubMed ID: 17729379 [Abstract] [Full Text] [Related]
25. Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD. Margulis AV, Abou-Ali A, Strazzeri MM, Ding Y, Kuyateh F, Frimpong EY, Levenson MS, Hammad TA. Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):942-51. PubMed ID: 23733623 [Abstract] [Full Text] [Related]
26. Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. Grigoriadis S, VonderPorten EH, Mamisashvili L, Roerecke M, Rehm J, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Ross LE. J Clin Psychiatry; 2013 Apr; 74(4):e293-308. PubMed ID: 23656855 [Abstract] [Full Text] [Related]
28. First-trimester use of paroxetine and congenital heart defects: a population-based case-control study. Bakker MK, Kerstjens-Frederikse WS, Buys CH, de Walle HE, de Jong-van den Berg LT. Birth Defects Res A Clin Mol Teratol; 2010 Feb; 88(2):94-100. PubMed ID: 19937603 [Abstract] [Full Text] [Related]
29. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update. Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C, Pergola A, Fornai M, Antonioli L, Colucci R, Corona T, Blandizzi C. Postgrad Med; 2010 Jul; 122(4):49-65. PubMed ID: 20675971 [Abstract] [Full Text] [Related]
34. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC. Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456 [Abstract] [Full Text] [Related]
35. First-trimester exposure to bupropion and risk of cardiac malformations. Louik C, Kerr S, Mitchell AA. Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1066-75. PubMed ID: 24920293 [Abstract] [Full Text] [Related]
38. Prenatal antidepressant use and risk of congenital malformations: A population-based cohort study. Chan JKN, Lee KCK, Wong CSM, Chang WC. Psychiatry Res; 2024 Sep; 339():116038. PubMed ID: 38889560 [Abstract] [Full Text] [Related]
39. Paroxetine use during pregnancy and perinatal outcomes including types of cardiac malformations in Quebec and France: a short communication. Bérard A, Sheehy O, Damase-Michel C, Crespin S. Curr Drug Saf; 2012 Jul; 7(3):207-10. PubMed ID: 22950376 [Abstract] [Full Text] [Related]
40. Publishing statistically significant results with questionable clinical importance: focus on antidepressant use in pregnancy. Einarson A. J Clin Psychiatry; 2012 Nov; 73(11):1443-6. PubMed ID: 23218161 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]